<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01435642</url>
  </required_header>
  <id_info>
    <org_study_id>INS-3956</org_study_id>
    <secondary_id>U1111-1122-1671</secondary_id>
    <nct_id>NCT01435642</nct_id>
  </id_info>
  <brief_title>A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes</brief_title>
  <acronym>Diabcare</acronym>
  <official_title>Diabcare Paediatric - A Survey-study on Diabetes Management, Complications and Psychosocial Aspects of Type 1 Childhood Diabetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novo Nordisk A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is conducted in Africa. The aim of this non-interventional study is to evaluate
      the current status of diabetes management, complications and psychosocial aspects for
      children with type 1 diabetes in Algeria.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean HbA1c (glycosylated haemoglobin)</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients on insulin therapy</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean duration of insulin therapy</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number of insulin injections/day</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean insulin units per day</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients on OAD or other treatments</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients having complications (ophthalmological, peripheral, renal and others)</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To quantify quality of life</measure>
    <time_frame>At the first visit (only one study visit) after 12 month of follow up</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">349</enrollment>
  <condition>Diabetes</condition>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No treatment given</intervention_name>
    <description>Subject will fill out a questionnaire when entering the non-interventional study</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with type 1 diabetes mellitus being treated at diabetes clinics will be selected
        according to the inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent obtained from the patient and his legal representative before any
             study-related activities (Study-related activities are any procedure related to
             recording of data according to the protocol)

          -  Type 1 diabetes

          -  Time since diabetes diagnosed at least 5 years

          -  Followed for diabetes at consultation for at least 12 months

        Exclusion Criteria:

          -  Patient previously included in this study

          -  Secondary diabetes

          -  Pregnant patient

          -  Patient consulting for an emergency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Global Clinical Registry (GCR, 1452)</last_name>
    <role>Study Director</role>
    <affiliation>Novo Nordisk A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novo Nordisk Investigational Site</name>
      <address>
        <city>Blida</city>
        <zip>16009</zip>
        <country>Algeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Algeria</country>
  </location_countries>
  <link>
    <url>http://novonordisk-trials.com</url>
    <description>Clinical Trials at Novo Nordisk</description>
  </link>
  <results_reference>
    <citation>La prise en charge du diabéte de type 1 chez l'enfant en Algérie (DiabCare Pédiatrique); Bensenouci A, Achir M et al.; Médecine des Maladies Métaboliques 2015; Doi: 10.1016/S1957-2557(14)70902-2</citation>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2011</study_first_submitted>
  <study_first_submitted_qc>September 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2011</study_first_posted>
  <last_update_submitted>January 19, 2017</last_update_submitted>
  <last_update_submitted_qc>January 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

